Forte Biosciences (FBRX) Other Operating Expenses (2016 - 2026)
Forte Biosciences (FBRX) reported Other Operating Expenses of $150000.0 for Q1 2026, little changed year-over-year from $150000.0 in Q1 2025, and little changed quarter-over-quarter from $150000.0 in Q4 2025.
Forte Biosciences (FBRX) Other Operating Expenses (2016 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has 8 years of Other Operating Expenses data on file, last reported at $150000.0 in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $150000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $600000.0 (changed 0.0% YoY), and the FY2025 annual result was $600000.0, up 25.26% from the prior year.
- Other Operating Expenses steadied at $150000.0 in Q1 2026 per FBRX's latest filing, from $150000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $150000.0 in Q2 2024 and troughed at $29000.0 in Q1 2024.
- A 3-year average of $136555.6 and a median of $150000.0 in 2024 frame the typical range for Other Operating Expenses.
- On a YoY basis, Other Operating Expenses climbed as much as 417.24% in 2025 and fell as far as 0.0% in 2025.
- A 3-year view of Other Operating Expenses shows it stood at $150000.0 in 2024, then changed by 0.0% to $150000.0 in 2025, then changed by 0.0% to $150000.0 in 2026.
- Business Quant data shows FBRX's Other Operating Expenses at $150000.0 in Q1 2026, $150000.0 in Q4 2025, and $150000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150,000.00 |
| Dec 31, 2025 | 150,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Jun 30, 2020 | 32.06 Mn |
| Mar 31, 2020 | -885,000.00 |
| Dec 31, 2019 | 9.15 Mn |
| Dec 31, 2018 | -1,000.00 |
| Dec 31, 2017 | -1,000.00 |
| Dec 31, 2016 | 1,000.00 |